HIV-Related Cancers:@0.719697:0.035749:0.914545:0.035749:0.914545:0.019993:0.719697:0.019993:0.013143:0.004349:0.013508:0.006388:0.011680:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
131:@0.950254:0.038184:0.981863:0.038184:0.981863:0.018587:0.950254:0.018587:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
on the palate and gingiva and is frequent-:@0.084242:0.096166:0.475158:0.096166:0.475158:0.080410:0.084242:0.080410:0.012604:0.011738:0.004378:0.006523:0.011738:0.012508:0.004387:0.013123:0.013143:0.003848:0.013143:0.006523:0.012508:0.004387:0.013143:0.011738:0.013181:0.004387:0.012950:0.003848:0.011738:0.012950:0.003848:0.010660:0.013143:0.004387:0.013143:0.011738:0.013181:0.004387:0.003848:0.007466:0.004387:0.006042:0.005711:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.006388
ly first detected by a dental practitioner.:@0.084242:0.112583:0.458222:0.112583:0.458222:0.096827:0.084242:0.096827:0.003848:0.010314:0.005330:0.004686:0.004686:0.005792:0.007466:0.006523:0.005330:0.013181:0.012508:0.006523:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330:0.013123:0.010314:0.005330:0.013143:0.005330:0.013181:0.012508:0.011738:0.006523:0.013143:0.003848:0.005330:0.013123:0.005792:0.013143:0.012450:0.006523:0.003848:0.006523:0.003848:0.012604:0.011738:0.012508:0.004353:0.005330
Prior to ART, 40% of patients had GIT in-:@0.102426:0.129000:0.475163:0.129000:0.475163:0.113244:0.102426:0.113244:0.011392:0.005792:0.003848:0.012604:0.005792:0.007174:0.006523:0.012604:0.007179:0.014239:0.011788:0.006229:0.005330:0.007183:0.010660:0.010660:0.014913:0.007197:0.012604:0.006042:0.007181:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007197:0.011738:0.013143:0.013181:0.007187:0.016779:0.004349:0.008197:0.007185:0.003848:0.011738:0.006388
volvement with weight  loss, nausea and :@0.084242:0.145418:0.480492:0.145418:0.480492:0.129662:0.084242:0.129662:0.010660:0.012604:0.003848:0.010660:0.012508:0.018049:0.012508:0.011738:0.006523:0.009140:0.015990:0.003848:0.006523:0.011738:0.009140:0.015990:0.012508:0.003848:0.012950:0.011738:0.006523:0.005330:0.003800:0.003848:0.012604:0.007466:0.007466:0.005330:0.009140:0.011738:0.013143:0.011699:0.007466:0.012508:0.013143:0.009140:0.013143:0.011738:0.013181:0.005330
vomiting, abdominal  pain, bleeding, ob-:@0.084242:0.161835:0.475144:0.161835:0.475144:0.146079:0.084242:0.146079:0.010660:0.012604:0.018049:0.003848:0.006523:0.003848:0.011738:0.012950:0.005330:0.008582:0.013143:0.013123:0.013181:0.012604:0.018049:0.003848:0.011738:0.013143:0.003848:0.005330:0.003264:0.013123:0.013143:0.003848:0.011738:0.005330:0.008582:0.013123:0.003848:0.012508:0.012508:0.013181:0.003848:0.011738:0.012950:0.005330:0.008582:0.012604:0.013123:0.006388
struction and diarrhoea.:@0.084242:0.178253:0.309223:0.178253:0.309223:0.162497:0.084242:0.162497:0.007466:0.006523:0.005792:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.013143:0.011738:0.013181:0.005330:0.013181:0.003848:0.013143:0.005792:0.006329:0.011738:0.012604:0.012508:0.013143:0.005330
Treatment:@0.084242:0.211390:0.187296:0.211390:0.187296:0.193369:0.084242:0.193369:0.008980:0.006842:0.013683:0.014111:0.006414:0.020098:0.013683:0.012828:0.006414
ART is central to the management of Ka-:@0.084242:0.228951:0.475163:0.228951:0.475163:0.213196:0.084242:0.213196:0.014239:0.011786:0.008197:0.007083:0.003848:0.007466:0.007100:0.012450:0.012508:0.011738:0.006523:0.005792:0.013143:0.003848:0.007081:0.006523:0.012604:0.007083:0.006523:0.011738:0.012508:0.007079:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.007081:0.012604:0.006042:0.007081:0.011372:0.013143:0.006388
posi’s sarcoma. The major goals of treat-:@0.084242:0.245369:0.475173:0.245369:0.475173:0.229613:0.084242:0.229613:0.013123:0.012604:0.007466:0.003848:0.006754:0.007466:0.007749:0.007466:0.013143:0.005657:0.012450:0.012604:0.018049:0.013143:0.005330:0.007735:0.008197:0.011738:0.012508:0.007735:0.018049:0.013143:0.003906:0.012604:0.005792:0.007735:0.012950:0.012604:0.013143:0.003848:0.007466:0.007747:0.012604:0.006042:0.007735:0.006523:0.005711:0.012508:0.013143:0.006523:0.006388
ment are symptom palliation, prevention :@0.084242:0.261786:0.480492:0.261786:0.480492:0.246030:0.084242:0.246030:0.018049:0.012508:0.011738:0.006523:0.008159:0.013143:0.005713:0.012508:0.008159:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.008159:0.013123:0.013143:0.003848:0.003848:0.003848:0.013143:0.006523:0.003848:0.012604:0.011749:0.005330:0.008159:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.005330
of  disease progression,  and  shrinkage  of :@0.084242:0.278204:0.480488:0.278204:0.480488:0.262448:0.084242:0.262448:0.012604:0.006042:0.005330:0.003773:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.009121:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330:0.003777:0.013143:0.011738:0.013181:0.005330:0.003777:0.007466:0.011738:0.005792:0.003848:0.011738:0.009660:0.013143:0.012950:0.012508:0.005330:0.003773:0.012604:0.006042:0.005330
tumour to alleviate oedema, organ com-:@0.084242:0.294621:0.475146:0.294621:0.475146:0.278865:0.084242:0.278865:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.006458:0.006523:0.012604:0.006465:0.013143:0.003848:0.003848:0.012508:0.010672:0.003848:0.013143:0.006523:0.012508:0.006473:0.012604:0.012508:0.013181:0.012508:0.018049:0.013143:0.005330:0.006464:0.012604:0.005792:0.012950:0.013143:0.011738:0.006469:0.012450:0.012604:0.018049:0.006388
promise and psychological stress.:@0.084242:0.311038:0.394468:0.311038:0.394468:0.295282:0.084242:0.295282:0.013123:0.005715:0.012604:0.018049:0.003848:0.007466:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.013123:0.007466:0.010314:0.012450:0.011738:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.007466:0.006523:0.005715:0.012508:0.007466:0.007466:0.005330
Depending on the clinical picture, treat-:@0.102426:0.327456:0.475163:0.327456:0.475163:0.311700:0.102426:0.311700:0.014316:0.012508:0.013123:0.012508:0.011738:0.013181:0.003848:0.011738:0.012950:0.004907:0.012604:0.011738:0.004907:0.006523:0.011738:0.012508:0.004907:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.004924:0.013123:0.003848:0.012450:0.006523:0.011699:0.005713:0.012508:0.005330:0.004907:0.006523:0.005711:0.012508:0.013143:0.006523:0.006388
ment is either local with intralesional thera-:@0.084242:0.343873:0.475152:0.343873:0.475152:0.328117:0.084242:0.328117:0.018049:0.012508:0.011738:0.006523:0.004618:0.003848:0.007466:0.004630:0.012508:0.003848:0.006523:0.011738:0.012508:0.005792:0.004618:0.003848:0.012604:0.012450:0.013143:0.003848:0.004618:0.015990:0.003848:0.006523:0.011738:0.004618:0.003848:0.011738:0.006523:0.005792:0.013143:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.013143:0.003848:0.004618:0.006523:0.011738:0.012508:0.005792:0.013150:0.006388
pies,  or  localised  superficial  beam  radia-:@0.084242:0.360291:0.475142:0.360291:0.475142:0.344535:0.084242:0.344535:0.013123:0.003848:0.012508:0.007466:0.005330:0.005330:0.003025:0.012604:0.005792:0.005330:0.003021:0.003848:0.012604:0.012450:0.013143:0.003848:0.003848:0.007466:0.012508:0.013181:0.005330:0.003023:0.007466:0.011699:0.013123:0.012508:0.005792:0.004686:0.004686:0.012450:0.003848:0.013143:0.003848:0.005330:0.003025:0.013123:0.012508:0.013143:0.018049:0.005330:0.003021:0.005792:0.013143:0.013181:0.003848:0.013143:0.006388
tion, or systemic chemotherapy for more :@0.084242:0.376708:0.480484:0.376708:0.480484:0.360952:0.084242:0.360952:0.006523:0.003848:0.012604:0.011738:0.005330:0.008009:0.012604:0.005792:0.008007:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.003848:0.012450:0.008024:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013123:0.013123:0.010314:0.008024:0.006042:0.012604:0.005792:0.008007:0.018049:0.012604:0.005709:0.012508:0.005330
widespread disease.:@0.084242:0.393125:0.275693:0.393125:0.275693:0.377369:0.084242:0.377369:0.015990:0.003848:0.013181:0.012508:0.007466:0.013123:0.005723:0.012508:0.013143:0.013181:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
The chemotherapies used include dox-:@0.102426:0.409543:0.475165:0.409543:0.475165:0.393787:0.102426:0.393787:0.008197:0.011738:0.012508:0.007683:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012496:0.005792:0.013143:0.013123:0.003848:0.012508:0.007466:0.007697:0.011699:0.007466:0.012508:0.013181:0.007697:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007697:0.013181:0.012604:0.009236:0.006388
orubicin (including liposomal versions), :@0.084242:0.425960:0.480463:0.425960:0.480463:0.410204:0.084242:0.410204:0.012604:0.005792:0.011699:0.013123:0.003848:0.012450:0.003848:0.011738:0.016779:0.007100:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.003848:0.011738:0.012950:0.016779:0.003848:0.003848:0.013123:0.012604:0.007466:0.012604:0.018049:0.013143:0.003848:0.016779:0.010660:0.012508:0.005792:0.007466:0.003848:0.012604:0.011738:0.007466:0.007100:0.005330:0.005330
paclitaxel  bleomycin, the vincaloids and :@0.084242:0.442378:0.480474:0.442378:0.480474:0.426622:0.084242:0.426622:0.013123:0.013143:0.012450:0.003848:0.003848:0.006523:0.013143:0.009236:0.012508:0.003848:0.005330:0.003129:0.013123:0.003848:0.012508:0.012604:0.018049:0.010314:0.012450:0.003848:0.011738:0.005330:0.008447:0.006523:0.011738:0.012508:0.008447:0.010660:0.003848:0.011738:0.012450:0.013143:0.003848:0.012604:0.003848:0.013181:0.007466:0.008447:0.013143:0.011738:0.013181:0.005330
etoposide.  Steroids also have a place in :@0.084242:0.458795:0.480501:0.458795:0.480501:0.443039:0.084242:0.443039:0.012508:0.006523:0.012604:0.013123:0.012604:0.007466:0.003848:0.013181:0.012508:0.005330:0.005330:0.003142:0.009583:0.006523:0.012508:0.005709:0.012604:0.003848:0.013181:0.007466:0.008486:0.013143:0.003848:0.007466:0.012604:0.008486:0.011738:0.013143:0.010660:0.012508:0.008486:0.013143:0.008486:0.013123:0.003848:0.013143:0.012450:0.012508:0.008486:0.003848:0.011738:0.005330
the management of Kaposi’s sarcoma.:@0.084242:0.475212:0.448924:0.475212:0.448924:0.459456:0.084242:0.459456:0.006523:0.011738:0.012508:0.005330:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.011372:0.013143:0.013123:0.012604:0.007466:0.003848:0.006754:0.007466:0.005330:0.007466:0.013143:0.005638:0.012450:0.012604:0.018049:0.013143:0.005330
The prognosis has improved with the in-:@0.102426:0.491630:0.475163:0.491630:0.475163:0.475874:0.102426:0.475874:0.008197:0.011738:0.012508:0.006642:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.006646:0.011738:0.013143:0.007466:0.006658:0.003848:0.018049:0.013123:0.005719:0.012604:0.010660:0.012508:0.013181:0.006648:0.015990:0.003848:0.006523:0.011738:0.006658:0.006523:0.011738:0.012508:0.006644:0.003848:0.011738:0.006388
troduction of ART and often treatment is :@0.084242:0.508047:0.480490:0.508047:0.480490:0.492291:0.084242:0.492291:0.006523:0.005709:0.012604:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.008186:0.012604:0.006042:0.008197:0.014239:0.011792:0.008197:0.008197:0.013143:0.011738:0.013181:0.008197:0.012604:0.006042:0.006523:0.012508:0.011738:0.008184:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.008188:0.003848:0.007466:0.005330
intermittent  and  ongoing.  The  five-year :@0.084242:0.524465:0.480490:0.524465:0.480490:0.508709:0.084242:0.508709:0.003848:0.011738:0.006523:0.012508:0.006319:0.018049:0.003848:0.006523:0.006523:0.012508:0.011738:0.006523:0.005330:0.006998:0.013143:0.011738:0.013181:0.005330:0.007008:0.012604:0.011738:0.012950:0.012604:0.003848:0.011738:0.012950:0.005330:0.005330:0.006987:0.008197:0.011738:0.012508:0.005330:0.007004:0.004686:0.004686:0.010660:0.012508:0.006388:0.010314:0.012508:0.013143:0.005792:0.005330
survival in  patients  with  limited  stage  dis-:@0.084242:0.540882:0.475129:0.540882:0.475129:0.525126:0.084242:0.525126:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.008332:0.003848:0.011738:0.005330:0.002992:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.002986:0.015990:0.003848:0.006523:0.011738:0.005330:0.002990:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.005330:0.002992:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.002986:0.013181:0.003848:0.007466:0.006388
ease is over 80%, but falls if HIV is not con-:@0.084242:0.557299:0.475136:0.557299:0.475136:0.541543:0.084242:0.541543:0.012508:0.013143:0.007466:0.012508:0.005888:0.003848:0.007466:0.005888:0.012604:0.010660:0.012508:0.005792:0.005888:0.010660:0.010660:0.014913:0.005330:0.005888:0.013123:0.011699:0.006523:0.005888:0.006042:0.013143:0.003848:0.003848:0.007466:0.005902:0.003848:0.006042:0.005888:0.013143:0.004349:0.013508:0.005888:0.003848:0.007466:0.005888:0.011738:0.012604:0.006523:0.005879:0.012450:0.012604:0.011738:0.006388
trolled or in extensive disease.:@0.084242:0.573717:0.360211:0.573717:0.360211:0.557961:0.084242:0.557961:0.006523:0.005709:0.012604:0.003848:0.003848:0.012508:0.013181:0.005330:0.012604:0.005792:0.005330:0.003848:0.011738:0.005330:0.012508:0.009236:0.006523:0.012508:0.011738:0.007466:0.003848:0.010660:0.012508:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
NON-HODGKIN’S LYMPHOMA:@0.084242:0.606808:0.387845:0.606808:0.387845:0.588992:0.084242:0.588992:0.015822:0.017960:0.015822:0.008980:0.014539:0.017960:0.014966:0.017960:0.013256:0.005987:0.015822:0.005987:0.011118:0.005987:0.009407:0.013256:0.019242:0.011973:0.014539:0.017960:0.019242:0.015822
Ten  percent  of  HIV-infected  patients  de-:@0.084242:0.624369:0.475158:0.624369:0.475158:0.608613:0.084242:0.608613:0.007254:0.012508:0.011738:0.005330:0.003292:0.013123:0.012508:0.005655:0.012450:0.012508:0.011738:0.006523:0.005330:0.003290:0.012604:0.006042:0.005330:0.003298:0.013143:0.004349:0.013508:0.006388:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330:0.003298:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.003300:0.013181:0.012508:0.006388
velop non-Hodgkin’s lymphoma (NHL). :@0.084242:0.640786:0.480472:0.640786:0.480472:0.625030:0.084242:0.625030:0.010660:0.012508:0.003848:0.012604:0.013123:0.015894:0.011738:0.012604:0.011738:0.006388:0.013143:0.012594:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.015894:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.015894:0.007100:0.014239:0.013143:0.008890:0.007100:0.005330:0.005330
This disease is more common in males than :@0.084242:0.657204:0.480503:0.657204:0.480503:0.641448:0.084242:0.641448:0.008197:0.011738:0.003848:0.007466:0.004310:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.004310:0.003848:0.007466:0.004310:0.018049:0.012604:0.005709:0.012508:0.004299:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.004291:0.003848:0.011738:0.004310:0.018049:0.013143:0.003848:0.012508:0.007466:0.004310:0.006523:0.011738:0.013143:0.011738:0.005330
females.:@0.084242:0.673621:0.163136:0.673621:0.163136:0.657865:0.084242:0.657865:0.006042:0.012508:0.018049:0.013143:0.003848:0.012508:0.007466:0.005330
The three main non-Hodgkin’s lymphomas :@0.084242:0.706456:0.480474:0.706456:0.480474:0.690700:0.084242:0.690700:0.008197:0.011738:0.012508:0.005138:0.006523:0.011738:0.005707:0.012508:0.012508:0.005138:0.018049:0.013143:0.003848:0.011738:0.005138:0.011738:0.012604:0.011738:0.006388:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.005138:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.007466:0.005330
are:@0.084242:0.722873:0.115609:0.722873:0.115609:0.707117:0.084242:0.707117:0.013144:0.005715:0.012508
i.  Systemic NHL (>80%).:@0.084242:0.739290:0.298584:0.739290:0.298584:0.723535:0.084242:0.723535:0.003848:0.005330:0.005330:0.004734:0.009583:0.010314:0.007466:0.006523:0.012508:0.018049:0.003848:0.012450:0.005330:0.014239:0.013143:0.008890:0.005330:0.007100:0.011661:0.010660:0.010660:0.014913:0.007100:0.005330
 :@0.084242:0.752565:0.087809:0.752565:0.087809:0.744125:0.084242:0.744125:0.003566
n   :@0.103485:0.752565:0.130565:0.752565:0.130565:0.744125:0.103485:0.744125:0.009762:0.003566:0.010186:0.003566
Diffuse large B-cell (75%):@0.127003:0.755684:0.353758:0.755684:0.353758:0.739929:0.127003:0.739929:0.014316:0.003848:0.006104:0.006042:0.011699:0.007466:0.012508:0.005330:0.003848:0.013143:0.005809:0.012950:0.012508:0.005330:0.011045:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.007100:0.010660:0.010660:0.014913:0.007100
 :@0.084242:0.768980:0.087809:0.768980:0.087809:0.760540:0.084242:0.760540:0.003566
n   :@0.103485:0.768980:0.130565:0.768980:0.130565:0.760540:0.103485:0.760540:0.009762:0.003566:0.010186:0.003566
Burkitt’s lymphoma (15%):@0.127003:0.772099:0.358278:0.772099:0.358278:0.756343:0.127003:0.756343:0.011045:0.011699:0.005792:0.009660:0.003848:0.006523:0.006523:0.006754:0.007466:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.007100:0.010660:0.010660:0.014913:0.007100
 :@0.084242:0.785394:0.087809:0.785394:0.087809:0.776954:0.084242:0.776954:0.003566
n   :@0.103485:0.785394:0.130565:0.785394:0.130565:0.776954:0.103485:0.776954:0.009762:0.003566:0.010186:0.003566
Indolent NHL (<10%):@0.127003:0.788513:0.312519:0.788513:0.312519:0.772757:0.127003:0.772757:0.004349:0.011738:0.013181:0.012604:0.003848:0.012508:0.011738:0.006523:0.005330:0.014239:0.013143:0.008890:0.005330:0.007100:0.011661:0.010660:0.010660:0.014913:0.007100
 :@0.084242:0.801809:0.087809:0.801809:0.087809:0.793369:0.084242:0.793369:0.003566
n   :@0.103485:0.801809:0.130565:0.801809:0.130565:0.793369:0.103485:0.793369:0.009762:0.003566:0.010186:0.003566
T-cell lymphoma (1-3%):@0.127003:0.804928:0.342595:0.804928:0.342595:0.789172:0.127003:0.789172:0.008197:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.007100:0.010660:0.006388:0.010660:0.014913:0.007100
 :@0.084242:0.818223:0.087809:0.818223:0.087809:0.809783:0.084242:0.809783:0.003566
n   :@0.103485:0.818223:0.130565:0.818223:0.130565:0.809783:0.103485:0.809783:0.009762:0.003566:0.010186:0.003566
Plasmablastic lymphoma (<1%):@0.127003:0.821342:0.417410:0.821342:0.417410:0.805587:0.127003:0.805587:0.011392:0.003848:0.013143:0.007466:0.018049:0.013143:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.007100:0.011661:0.010660:0.014913:0.007100
ii.  Primary central nervous system (CNS) :@0.084247:0.837760:0.480486:0.837760:0.480486:0.822004:0.084247:0.822004:0.003848:0.003848:0.005330:0.006215:0.000000:0.011392:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.012219:0.012450:0.012508:0.011738:0.006523:0.005792:0.013143:0.003848:0.012219:0.011738:0.012508:0.005792:0.010660:0.012604:0.011699:0.007466:0.012219:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.012219:0.007100:0.015644:0.014239:0.009583:0.007100:0.005330
lymphoma (15%):@0.103489:0.854177:0.260122:0.854177:0.260122:0.838421:0.103489:0.838421:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.007100:0.010660:0.010660:0.014913:0.007100
iii. Primary effusion lymphoma – rare (<5%):@0.084247:0.870595:0.469533:0.870595:0.469533:0.854839:0.084247:0.854839:0.003848:0.003848:0.003848:0.005330:0.002367:0.011392:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.005330:0.012508:0.006088:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.009621:0.005330:0.005792:0.013143:0.005703:0.012508:0.005330:0.007100:0.011661:0.010660:0.014913:0.007100
The  general management  of  non-Hodg-:@0.084247:0.903429:0.475156:0.903429:0.475156:0.887674:0.084247:0.887674:0.008197:0.011738:0.012508:0.005330:0.003735:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.009082:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.003731:0.012604:0.006042:0.005330:0.003743:0.011738:0.012604:0.011738:0.006388:0.013143:0.012604:0.013181:0.012921:0.006388
kin’s lymphoma is identical in the HIV-in-:@0.084247:0.919847:0.475118:0.919847:0.475118:0.904091:0.084247:0.904091:0.009660:0.003848:0.011738:0.006754:0.007466:0.008736:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.008736:0.003848:0.007466:0.008736:0.003848:0.013181:0.012508:0.011738:0.006523:0.003848:0.012450:0.013143:0.003848:0.008736:0.003848:0.011738:0.008736:0.006523:0.011738:0.012508:0.008736:0.013143:0.004349:0.013508:0.006388:0.003848:0.011738:0.006388
fected patient to that of the non-infected :@0.084247:0.936264:0.480500:0.936264:0.480500:0.920508:0.084247:0.920508:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.005428:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.005432:0.006523:0.012604:0.005426:0.006523:0.011738:0.013143:0.006523:0.005428:0.012604:0.006042:0.005430:0.006523:0.011738:0.012508:0.005426:0.011738:0.012604:0.011738:0.006388:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330
patient. However, due to various factors, :@0.523647:0.096186:0.919900:0.096186:0.919900:0.080430:0.523647:0.080430:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.005330:0.008120:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003766:0.005330:0.008120:0.013181:0.011699:0.012508:0.008120:0.006523:0.012604:0.008120:0.010660:0.013143:0.005792:0.003848:0.012604:0.011699:0.007466:0.008120:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.005330:0.005330
treatment may need to be tailored to co-:@0.523647:0.112630:0.914568:0.112630:0.914568:0.096874:0.523647:0.096874:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005642:0.018049:0.013143:0.010314:0.005657:0.011738:0.012508:0.012508:0.013181:0.005648:0.006523:0.012604:0.005648:0.013123:0.012508:0.005657:0.006523:0.013143:0.003848:0.003848:0.012604:0.005717:0.012508:0.013181:0.005657:0.006523:0.012604:0.005648:0.012450:0.012604:0.006388
morbidities found in this population.:@0.523647:0.129073:0.853770:0.129073:0.853770:0.113318:0.523647:0.113318:0.018049:0.012604:0.005792:0.013123:0.003848:0.013181:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.006042:0.012604:0.011699:0.011738:0.013181:0.005330:0.003848:0.011738:0.005330:0.006523:0.011738:0.003848:0.007466:0.005330:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
Outcomes related to presenting CD4 :@0.541831:0.145517:0.919885:0.145517:0.919885:0.129761:0.541831:0.129761:0.016722:0.011699:0.006523:0.012450:0.012604:0.018049:0.012508:0.007466:0.012354:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.012354:0.006523:0.012604:0.012354:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.003848:0.011738:0.012950:0.012354:0.015644:0.014316:0.010660:0.005330
counts  are  unclear,  but  low CD4 counts :@0.523647:0.161961:0.919912:0.161961:0.919912:0.146205:0.523647:0.146205:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.005330:0.003947:0.013143:0.005715:0.012508:0.005330:0.003952:0.011699:0.011738:0.012450:0.003848:0.012508:0.013143:0.003772:0.005330:0.005330:0.003952:0.013123:0.011699:0.006523:0.005330:0.003952:0.003848:0.012604:0.015990:0.009294:0.015644:0.014316:0.010660:0.009294:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.005330
seem  to  correlate  with  more  advanced :@0.523647:0.178405:0.919881:0.178405:0.919881:0.162649:0.523647:0.162649:0.007466:0.012508:0.012508:0.018049:0.005330:0.004510:0.006523:0.012604:0.005330:0.004505:0.012450:0.012604:0.005792:0.005703:0.012508:0.003848:0.013143:0.006523:0.012508:0.005330:0.004510:0.015990:0.003848:0.006523:0.011738:0.005330:0.004510:0.018049:0.012604:0.005709:0.012508:0.005330:0.004508:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005330
stage  (Ann  Arbor  III and  IV) and  poorer :@0.523647:0.194849:0.919908:0.194849:0.919908:0.179093:0.523647:0.179093:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.004026:0.007100:0.014239:0.011738:0.011738:0.005330:0.004018:0.014239:0.005792:0.013123:0.012604:0.005792:0.005330:0.004020:0.004349:0.004349:0.004349:0.009371:0.013143:0.011738:0.013181:0.005330:0.004027:0.004349:0.013508:0.007100:0.009371:0.013143:0.011738:0.013181:0.005330:0.004029:0.013123:0.012604:0.012604:0.005705:0.012508:0.005792:0.005330
prognostic features, such as B-symptoms, :@0.523647:0.211293:0.919879:0.211293:0.919879:0.195537:0.523647:0.195537:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.007658:0.006042:0.012508:0.013143:0.006523:0.011699:0.005707:0.012508:0.007466:0.005330:0.007658:0.007466:0.011699:0.012450:0.011738:0.007658:0.013143:0.007466:0.007658:0.011045:0.006388:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330:0.005330
bone-marrow  and  extranodal involve-:@0.523647:0.227737:0.914553:0.227737:0.914553:0.211981:0.523647:0.211981:0.013123:0.012604:0.011738:0.012508:0.006388:0.018049:0.013143:0.005792:0.005705:0.012604:0.015990:0.005330:0.011746:0.013143:0.011738:0.013181:0.005330:0.011747:0.012508:0.009236:0.006523:0.005792:0.013143:0.011738:0.012604:0.013170:0.013143:0.003848:0.017087:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.006388
ment at presentation. Stage and prognos-:@0.523647:0.244180:0.914556:0.244180:0.914556:0.228424:0.523647:0.228424:0.018049:0.012508:0.011738:0.006523:0.004868:0.013143:0.006523:0.004868:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.004855:0.009583:0.006523:0.013143:0.012950:0.012508:0.004868:0.013143:0.011738:0.013181:0.004868:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007441:0.006388
tic features are known independent indi-:@0.523647:0.260624:0.914549:0.260624:0.914549:0.244868:0.523647:0.244868:0.006523:0.003848:0.012450:0.007562:0.006042:0.012508:0.013143:0.006523:0.011699:0.005711:0.012508:0.007466:0.007562:0.013143:0.005715:0.012508:0.007562:0.009660:0.011738:0.012604:0.015990:0.011738:0.007551:0.003848:0.011738:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.012508:0.011738:0.006523:0.007551:0.003848:0.011738:0.013181:0.003848:0.006388
cators of outcomes.:@0.523647:0.277068:0.710164:0.277068:0.710164:0.261312:0.523647:0.261312:0.012450:0.013143:0.006523:0.012604:0.005792:0.007466:0.005330:0.012604:0.006042:0.005330:0.012604:0.011699:0.006523:0.012450:0.012604:0.018049:0.012508:0.007466:0.005330
7:@0.710122:0.271423:0.716337:0.271423:0.716337:0.262237:0.710122:0.262237:0.006215
Treatment:@0.523636:0.310252:0.626690:0.310252:0.626690:0.292231:0.523636:0.292231:0.008980:0.006842:0.013683:0.014111:0.006414:0.020098:0.013683:0.012828:0.006414
The optimal therapy for HIV-infected pa-:@0.523636:0.327842:0.914526:0.327842:0.914526:0.312086:0.523636:0.312086:0.008005:0.011545:0.012315:0.009487:0.012411:0.012931:0.006331:0.003656:0.017857:0.012950:0.003656:0.009487:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.009487:0.005850:0.012411:0.005600:0.009487:0.012950:0.004156:0.013316:0.006196:0.003656:0.011545:0.005850:0.012315:0.012257:0.006331:0.012315:0.012989:0.009487:0.012931:0.012950:0.006388
tients is still controversial and most studies :@0.523636:0.344286:0.919860:0.344286:0.919860:0.328530:0.523636:0.328530:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.008109:0.003656:0.007274:0.008107:0.007274:0.006331:0.003656:0.003656:0.003656:0.008109:0.012257:0.012411:0.011545:0.006331:0.005519:0.012411:0.010468:0.012315:0.005600:0.007274:0.003656:0.012950:0.003656:0.008109:0.012950:0.011545:0.012989:0.008109:0.017857:0.012411:0.007274:0.006331:0.008107:0.007274:0.006331:0.011507:0.012989:0.003656:0.012315:0.007470:0.005330
are based on patients in developed coun-:@0.523636:0.360729:0.914543:0.360729:0.914543:0.344973:0.523636:0.344973:0.012950:0.005521:0.012315:0.005446:0.012931:0.012950:0.007274:0.012315:0.012989:0.005446:0.012411:0.011545:0.005446:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005446:0.003656:0.011545:0.005446:0.012989:0.012315:0.010468:0.012315:0.003656:0.012411:0.012931:0.012315:0.012989:0.005446:0.012257:0.012411:0.011507:0.011545:0.006388
tries who have different risk factors to those :@0.523636:0.377173:0.919899:0.377173:0.919899:0.361417:0.523636:0.361417:0.006331:0.005600:0.003656:0.012315:0.007274:0.004974:0.015798:0.011545:0.012411:0.004974:0.011545:0.012950:0.010468:0.012315:0.004974:0.012989:0.003656:0.005905:0.005850:0.012315:0.005521:0.012315:0.011545:0.006331:0.004974:0.005600:0.003656:0.007274:0.009467:0.004974:0.005850:0.012950:0.012257:0.006331:0.012411:0.005600:0.007274:0.004974:0.006331:0.012411:0.004974:0.006331:0.011545:0.012411:0.007274:0.012506:0.005330
locally. The administration of optimal doses :@0.523636:0.393617:0.919870:0.393617:0.919870:0.377861:0.523636:0.377861:0.003656:0.012411:0.012257:0.012950:0.003656:0.003656:0.010122:0.005138:0.005186:0.008005:0.011545:0.012315:0.005186:0.012950:0.012989:0.017857:0.003656:0.011545:0.003656:0.007274:0.006331:0.005600:0.012950:0.006331:0.003656:0.012411:0.011545:0.005186:0.012411:0.005850:0.005186:0.012411:0.012931:0.006331:0.003656:0.017857:0.012950:0.003656:0.005186:0.012989:0.012411:0.007274:0.012315:0.007470:0.005330
(dose frequency and dose intensity) is a :@0.523636:0.410061:0.919874:0.410061:0.919874:0.394305:0.523636:0.394305:0.006908:0.012989:0.012411:0.007274:0.012315:0.009737:0.005850:0.005521:0.012315:0.012931:0.011507:0.012315:0.011545:0.012257:0.010122:0.009737:0.012950:0.011545:0.012989:0.009737:0.012989:0.012411:0.007274:0.012315:0.009737:0.003656:0.011545:0.006331:0.012315:0.011545:0.007274:0.003656:0.006331:0.010122:0.006908:0.009737:0.003656:0.007274:0.009737:0.013143:0.005330
challenge and the immunosuppression of :@0.523636:0.426505:0.919889:0.426505:0.919889:0.410749:0.523636:0.410749:0.012257:0.011545:0.012950:0.003656:0.003656:0.012315:0.011545:0.012758:0.012315:0.008082:0.012950:0.011545:0.012989:0.008082:0.006331:0.011545:0.012315:0.008082:0.003656:0.017857:0.017857:0.011507:0.011545:0.012411:0.007274:0.011507:0.012931:0.012931:0.005519:0.012315:0.007274:0.007274:0.003656:0.012411:0.011545:0.008082:0.012411:0.006040:0.005330
HIV-infected patients may limit this. A high :@0.523636:0.442949:0.919893:0.442949:0.919893:0.427193:0.523636:0.427193:0.012950:0.004156:0.013316:0.006196:0.003656:0.011545:0.005850:0.012315:0.012257:0.006331:0.012315:0.012989:0.006658:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.006658:0.017857:0.012950:0.010122:0.006658:0.003656:0.003656:0.017857:0.003656:0.006331:0.006658:0.006331:0.011545:0.003656:0.007274:0.005138:0.006658:0.014047:0.006658:0.011545:0.003656:0.012758:0.011736:0.005330
rate of dose reduction, treatment delays or :@0.523636:0.459392:0.919904:0.459392:0.919904:0.443637:0.523636:0.443637:0.005600:0.012950:0.006331:0.012315:0.004637:0.012411:0.005850:0.004637:0.012989:0.012411:0.007274:0.012315:0.004637:0.005521:0.012315:0.012989:0.011507:0.012257:0.006331:0.003656:0.012411:0.011545:0.005138:0.004637:0.006331:0.005521:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.004637:0.012989:0.012315:0.003656:0.012950:0.010122:0.007274:0.004637:0.012411:0.005786:0.005330
treatment interruption is seen in these pa-:@0.523636:0.475836:0.914568:0.475836:0.914568:0.460080:0.523636:0.460080:0.006331:0.005519:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.007397:0.003656:0.011545:0.006331:0.012315:0.005600:0.005600:0.011507:0.012931:0.006331:0.003656:0.012411:0.011545:0.007397:0.003656:0.007274:0.007397:0.007274:0.012315:0.012315:0.011545:0.007397:0.003656:0.011545:0.007397:0.006331:0.011545:0.012315:0.007274:0.012315:0.007397:0.012931:0.012950:0.006388
tients. Low CD4 counts limit the use of bone :@0.523636:0.492280:0.919951:0.492280:0.919951:0.476524:0.523636:0.476524:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005138:0.004503:0.008698:0.012411:0.015798:0.004503:0.015452:0.014124:0.010468:0.004503:0.012257:0.012411:0.011507:0.011545:0.006331:0.007274:0.004503:0.003656:0.003656:0.017857:0.003656:0.006331:0.004503:0.006331:0.011545:0.012315:0.004503:0.011507:0.007274:0.012315:0.004503:0.012411:0.005850:0.004503:0.012931:0.012411:0.011545:0.012506:0.005330
marrow-suppressive therapies and careful :@0.523636:0.508724:0.919889:0.508724:0.919889:0.492968:0.523636:0.492968:0.017857:0.012950:0.005600:0.005519:0.012411:0.015798:0.006196:0.007274:0.011507:0.012931:0.012931:0.005521:0.012315:0.007274:0.007274:0.003656:0.010468:0.012315:0.008159:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.003656:0.012315:0.007274:0.008159:0.012950:0.011545:0.012989:0.008159:0.012257:0.012950:0.005521:0.012315:0.005850:0.011507:0.003850:0.005330
monitoring of blood counts and the higher :@0.523636:0.525168:0.919949:0.525168:0.919949:0.509412:0.523636:0.509412:0.017857:0.012411:0.011545:0.003656:0.006331:0.012411:0.005600:0.003656:0.011545:0.012758:0.005657:0.012411:0.005850:0.005657:0.012931:0.003656:0.012411:0.012411:0.012989:0.005657:0.012257:0.012411:0.011507:0.011545:0.006331:0.007274:0.005657:0.012950:0.011545:0.012989:0.005657:0.006331:0.011545:0.012315:0.005657:0.011545:0.003656:0.012758:0.011545:0.012315:0.005788:0.005330
use of prophylactic neutrophil support us-:@0.523636:0.541612:0.914578:0.541612:0.914578:0.525856:0.523636:0.525856:0.011507:0.007274:0.012315:0.007889:0.012411:0.005850:0.007889:0.012931:0.005521:0.012411:0.012931:0.011545:0.010122:0.003656:0.012950:0.012257:0.006331:0.003656:0.012257:0.007889:0.011545:0.012315:0.011507:0.006331:0.005519:0.012411:0.012931:0.011545:0.003656:0.003656:0.007889:0.007274:0.011507:0.012931:0.012931:0.012411:0.005600:0.006331:0.007889:0.011507:0.007274:0.006388
ing granulocyte colony-stimulating factors :@0.523636:0.558056:0.919897:0.558056:0.919897:0.542300:0.523636:0.542300:0.003656:0.011545:0.012758:0.007510:0.012758:0.005600:0.012950:0.011545:0.011507:0.003656:0.012411:0.012257:0.010122:0.006331:0.012315:0.007512:0.012257:0.012411:0.003656:0.012411:0.011545:0.010122:0.006196:0.007274:0.006331:0.003656:0.017857:0.011507:0.003656:0.012950:0.006331:0.003656:0.011545:0.012758:0.007510:0.005850:0.012950:0.012257:0.006331:0.012411:0.005600:0.007468:0.005330
is necessary. Patients with very low CD4 :@0.523636:0.574499:0.919841:0.574499:0.919841:0.558744:0.523636:0.558744:0.003656:0.007274:0.010603:0.011545:0.012315:0.012257:0.012315:0.007274:0.007274:0.012950:0.005600:0.010122:0.005138:0.010603:0.011199:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.010603:0.015798:0.003656:0.006331:0.011545:0.010603:0.010468:0.012315:0.005600:0.010122:0.010603:0.003656:0.012411:0.015798:0.010603:0.015452:0.014124:0.010664:0.005330
counts (<50-100 cells/µl) have a higher risk :@0.523636:0.590943:0.919816:0.590943:0.919816:0.575187:0.523636:0.575187:0.012257:0.012411:0.011507:0.011545:0.006331:0.007274:0.006658:0.006908:0.011468:0.010468:0.010468:0.006196:0.010468:0.010468:0.010468:0.006658:0.012257:0.012315:0.003656:0.003656:0.007274:0.008217:0.010891:0.003656:0.006908:0.006658:0.011545:0.012950:0.010468:0.012315:0.006658:0.012950:0.006658:0.011545:0.003656:0.012758:0.011545:0.012315:0.005600:0.006658:0.005600:0.003656:0.007274:0.009658:0.005330
of infection-related mortality if rituximab, a :@0.523636:0.607387:0.919895:0.607387:0.919895:0.591631:0.523636:0.591631:0.012411:0.005850:0.006119:0.003656:0.011545:0.005850:0.012315:0.012257:0.006331:0.003656:0.012411:0.011545:0.006196:0.005521:0.012315:0.003656:0.012950:0.006331:0.012315:0.012989:0.006119:0.017857:0.012411:0.005600:0.006331:0.012950:0.003656:0.003656:0.006331:0.010122:0.006119:0.003656:0.005850:0.006119:0.005600:0.003656:0.006331:0.011507:0.009044:0.003656:0.017857:0.012950:0.012931:0.005138:0.006119:0.013144:0.005330
monoclonal antibody against CD20 pro-:@0.523636:0.623831:0.914522:0.623831:0.914522:0.608075:0.523636:0.608075:0.017857:0.012411:0.011545:0.012411:0.012257:0.003656:0.012411:0.011545:0.012950:0.003656:0.010506:0.012950:0.011545:0.006331:0.003656:0.012931:0.012411:0.012989:0.010122:0.010506:0.012950:0.012758:0.012950:0.003656:0.011545:0.007274:0.006331:0.010506:0.015452:0.014124:0.010468:0.010468:0.010506:0.012931:0.005519:0.012411:0.006388
tein found on the surface of B-cell non-:@0.523636:0.640275:0.914538:0.640275:0.914538:0.624519:0.523636:0.624519:0.006331:0.012315:0.003656:0.011545:0.010122:0.005850:0.012411:0.011507:0.011545:0.012989:0.010122:0.012411:0.011545:0.010122:0.006331:0.011545:0.012315:0.010122:0.007274:0.011507:0.006515:0.005850:0.012950:0.012257:0.012315:0.010122:0.012411:0.005850:0.010122:0.010853:0.006196:0.012257:0.012315:0.003656:0.003656:0.010122:0.011545:0.012411:0.011545:0.006388
Hodgkin’s lymphomas, is used. Rituximab, :@0.523636:0.656719:0.919854:0.656719:0.919854:0.640963:0.523636:0.640963:0.012950:0.012411:0.012989:0.012758:0.009467:0.003656:0.011545:0.006562:0.007274:0.008659:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.017857:0.012950:0.007274:0.005138:0.008659:0.003656:0.007274:0.008659:0.011507:0.007274:0.012315:0.012989:0.005138:0.008659:0.011488:0.003656:0.006331:0.011507:0.009044:0.003656:0.017857:0.012950:0.012931:0.005328:0.005330
commonly used in combination with stand-:@0.523636:0.673163:0.914565:0.673163:0.914565:0.657407:0.523636:0.657407:0.012257:0.012411:0.017857:0.017857:0.012411:0.011545:0.003656:0.010122:0.004233:0.011507:0.007274:0.012315:0.012989:0.004233:0.003656:0.011545:0.004233:0.012257:0.012411:0.017857:0.012931:0.003656:0.011545:0.012950:0.006331:0.003656:0.012411:0.011545:0.004233:0.015798:0.003656:0.006331:0.011545:0.004233:0.007274:0.006331:0.012950:0.011545:0.012989:0.006388
ard chemotherapy for B-cell non-Hodgkin’s :@0.523636:0.689606:0.919877:0.689606:0.919877:0.673850:0.523636:0.673850:0.012950:0.005482:0.012989:0.004253:0.012257:0.011545:0.012315:0.017857:0.012411:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.004253:0.005850:0.012411:0.005600:0.004253:0.010853:0.006196:0.012257:0.012315:0.003656:0.003656:0.004253:0.011545:0.012411:0.011545:0.006196:0.012950:0.012411:0.012989:0.012758:0.009467:0.003656:0.011545:0.006562:0.007470:0.005330
lymphomas, reduces CD4 levels which :@0.523636:0.706050:0.919870:0.706050:0.919870:0.690294:0.523636:0.690294:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.017857:0.012950:0.007274:0.005138:0.015067:0.005521:0.012315:0.012989:0.011507:0.012257:0.012315:0.007274:0.015067:0.015452:0.014124:0.010468:0.015067:0.003656:0.012315:0.010468:0.012315:0.003656:0.007274:0.015067:0.015798:0.011545:0.003656:0.012257:0.011734:0.005330
may lead to catastrophic infections. Rituxi-:@0.523636:0.722494:0.914543:0.722494:0.914543:0.706738:0.523636:0.706738:0.017857:0.012950:0.010122:0.005773:0.003656:0.012315:0.012950:0.012989:0.005773:0.006331:0.012411:0.005773:0.012257:0.012950:0.006331:0.012950:0.007274:0.006331:0.005521:0.012411:0.012931:0.011545:0.003656:0.012257:0.005773:0.003656:0.011545:0.005850:0.012315:0.012257:0.006331:0.003656:0.012411:0.011545:0.007274:0.005138:0.005773:0.011488:0.003656:0.006331:0.011507:0.009044:0.003656:0.006388
mab is known to offer a 10-15% increase in :@0.523636:0.738938:0.919908:0.738938:0.919908:0.723182:0.523636:0.723182:0.017857:0.012950:0.012931:0.005715:0.003656:0.007274:0.005715:0.009467:0.011545:0.012411:0.015798:0.011545:0.005715:0.006331:0.012411:0.005715:0.012411:0.005907:0.005850:0.012315:0.005600:0.005715:0.012950:0.005715:0.010468:0.010468:0.006196:0.010468:0.010468:0.014720:0.005715:0.003656:0.011545:0.012257:0.005521:0.012315:0.012950:0.007274:0.012315:0.005715:0.003656:0.011734:0.005330
long-term survival in the general B-cell non-:@0.523636:0.755382:0.914518:0.755382:0.914518:0.739626:0.523636:0.739626:0.003656:0.012411:0.011545:0.012758:0.006196:0.006331:0.012315:0.006131:0.017857:0.004791:0.007274:0.011507:0.005600:0.010468:0.003656:0.010468:0.012950:0.003656:0.004791:0.003656:0.011545:0.004791:0.006331:0.011545:0.012315:0.004791:0.012758:0.012315:0.011545:0.012315:0.005600:0.012950:0.003656:0.004791:0.010853:0.006196:0.012257:0.012315:0.003656:0.003656:0.004791:0.011545:0.012411:0.011545:0.006388
Hodgkin’s lymphoma population.:@0.523636:0.771826:0.828513:0.771826:0.828513:0.756070:0.523636:0.756070:0.012950:0.012411:0.012989:0.012758:0.009467:0.003656:0.011545:0.006562:0.007274:0.005138:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.017857:0.012950:0.005138:0.012931:0.012411:0.012931:0.011507:0.003656:0.012950:0.006331:0.003656:0.012411:0.011545:0.005330
For  this reason, HIV-infected patients :@0.541820:0.788270:0.919881:0.788270:0.919881:0.772514:0.541820:0.772514:0.009333:0.012604:0.005792:0.005330:0.008628:0.006523:0.011738:0.003848:0.007466:0.013970:0.005713:0.012508:0.013143:0.007466:0.012604:0.011738:0.005330:0.013970:0.013143:0.004349:0.013508:0.006388:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.013970:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
with non-Hodgkin’s lymphoma need  to :@0.523636:0.804713:0.919902:0.804713:0.919902:0.788957:0.523636:0.788957:0.015990:0.003848:0.006523:0.011738:0.012277:0.011738:0.012604:0.011738:0.006388:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.012277:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.012277:0.011738:0.012508:0.012508:0.013181:0.005330:0.006935:0.006523:0.012604:0.005330
be on ART from the start of the systemic :@0.523636:0.821157:0.919866:0.821157:0.919866:0.805401:0.523636:0.805401:0.013123:0.012508:0.008255:0.012604:0.011738:0.008255:0.014239:0.011790:0.008197:0.008255:0.006042:0.005711:0.012604:0.018049:0.008255:0.006523:0.011738:0.012508:0.008255:0.007466:0.006523:0.013143:0.005792:0.006523:0.008255:0.012604:0.006042:0.008255:0.006523:0.011738:0.012508:0.008255:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.003848:0.012450:0.005330
therapy and need careful HIV-monitoring :@0.523636:0.837601:0.919902:0.837601:0.919902:0.821845:0.523636:0.821845:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.006821:0.013143:0.011738:0.013181:0.006831:0.011738:0.012508:0.012508:0.013181:0.006831:0.012450:0.013143:0.005713:0.012508:0.006042:0.011699:0.003848:0.006831:0.013143:0.004349:0.013508:0.006388:0.018049:0.012604:0.011738:0.003848:0.006523:0.012604:0.005792:0.003848:0.011738:0.012950:0.005330
during  treatment.  Discontinuation  of  ART :@0.523636:0.854045:0.919883:0.854045:0.919883:0.838289:0.523636:0.838289:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.005330:0.003718:0.006523:0.005713:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330:0.003716:0.014316:0.003848:0.007466:0.012450:0.012604:0.011738:0.006523:0.003848:0.011738:0.011699:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.003720:0.012604:0.006042:0.005330:0.003720:0.014239:0.011788:0.008197:0.005330
is not uncommon in HIV-infected NHL pa-:@0.523636:0.870489:0.914540:0.870489:0.914540:0.854733:0.523636:0.854733:0.003848:0.007466:0.006523:0.011738:0.012604:0.006523:0.006510:0.011699:0.011738:0.012450:0.012604:0.018049:0.018040:0.012604:0.011738:0.006512:0.003848:0.011738:0.006523:0.013143:0.004349:0.013508:0.006388:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.006523:0.014239:0.013143:0.008890:0.006514:0.013123:0.013143:0.006388
tients due to  treatment  complications. :@0.523636:0.886933:0.919885:0.886933:0.919885:0.871177:0.523636:0.871177:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.013893:0.013181:0.011699:0.012508:0.013893:0.006523:0.012604:0.005330:0.008553:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.008549:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.005330
This further complicates the management :@0.523636:0.903377:0.919883:0.903377:0.919883:0.887621:0.523636:0.887621:0.008197:0.011738:0.003848:0.007466:0.005619:0.006042:0.011699:0.005792:0.006523:0.011726:0.012508:0.005792:0.005609:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.012508:0.007466:0.005619:0.006523:0.011738:0.012508:0.005609:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330
and adds to the causes for death in this :@0.523636:0.919820:0.919885:0.919820:0.919885:0.904064:0.523636:0.904064:0.013143:0.011738:0.013181:0.008070:0.013143:0.013181:0.013181:0.007466:0.008082:0.006523:0.012604:0.008064:0.006523:0.011738:0.012508:0.008068:0.012450:0.013143:0.011699:0.007466:0.012508:0.007466:0.008082:0.006042:0.012604:0.005792:0.008063:0.013181:0.012508:0.013143:0.006523:0.011738:0.008066:0.003848:0.011738:0.008072:0.006523:0.011738:0.003848:0.007466:0.005330
cohort of patients.:@0.523636:0.936264:0.694855:0.936264:0.694855:0.920508:0.523636:0.920508:0.012450:0.012604:0.011738:0.012604:0.005792:0.006523:0.005330:0.012604:0.006042:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
7:@0.694826:0.930625:0.701041:0.930625:0.701041:0.921439:0.694826:0.921439:0.006215